Literature DB >> 6991419

Evidence for an immunological relationship between Streptococcus mutans and human cardiac tissue.

M Hughes, S M Machardy, A J Sheppard, N C Woods.   

Abstract

Two-dimensional immunoelectrophoresis, indirect immunofluorescence, and radioimmunoassay were used to demonstrate that antisera from rabbits immunized with some strains of Streptococcus mutans contain antibodies that cross-react with human cardiac tissue. These rabbits were sensitized to a shocking dose of human heart antigen, and anaphylactic deaths were sometimes produced. Myocarditis was also a result of the immunization procedure. Data obtained with all five techniques were comparable. Cross-reactivity could be associated with three antigens designated ID, IF, and HL. Antigens ID and IF were major immunogens of S. mutans Ingbritt, but HL antibodies were produced only after hyperimmunization. Corss-reactivity was of an immunological nature and not the result of nonspecific factors such as bacterial Fc reactive components or antibody elicited to growth medium constituents. These findings support the hypothesis that immunization with S. mutans can induce autoimmune reactions and indicate that antigens must be selected with caution before formulating any dental caries vaccine.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6991419      PMCID: PMC550804          DOI: 10.1128/iai.27.2.576-588.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  "Protein A" from S. aureus. I. Pseudo-immune reaction with human gamma-globulin.

Authors:  A Forsgren; J Sjöquist
Journal:  J Immunol       Date:  1966-12       Impact factor: 5.422

Review 2.  Autoimmunity to the heart in cardiac disease. Current concepts of the relation of autoimmunity to rheumatic fever, postcardiotomyand postinfarction syndromes and cardiomyopathies.

Authors:  M H Kaplan; J D Frengley
Journal:  Am J Cardiol       Date:  1969-10       Impact factor: 2.778

3.  Protein A in Staphylococcus aureus strains of human and bovine origin.

Authors:  G Kronvall; O Holmberg; T Ripa
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1972

4.  A surface component in group A, C, and G streptococci with non-immune reactivity for immunoglobulin G.

Authors:  G Kronvall
Journal:  J Immunol       Date:  1973-11       Impact factor: 5.422

5.  Crossed immunoelectrophoresis.

Authors:  B Weeke
Journal:  Scand J Immunol Suppl       Date:  1973

6.  A vaccine against dental caries. A pilot experiment in monkeys (Macaca irus).

Authors:  W H Bowen
Journal:  Br Dent J       Date:  1969-02-18       Impact factor: 1.626

7.  Chemical coupling of peptides and proteins to polysaccharides by means of cyanogen halides.

Authors:  R Axén; J Porath; S Ernback
Journal:  Nature       Date:  1967-06-24       Impact factor: 49.962

8.  Antigens of Streptococcus mutans. I. Characterization of a serotype-specific determinant from Streptococcus mutans.

Authors:  I Van de Rijn; A S Bleiweis
Journal:  Infect Immun       Date:  1973-05       Impact factor: 3.441

9.  Effects of local immunization with Streptococcus mutans on induction of salivary immunoglobulin A antibody and experimental dental caries in rats.

Authors:  M A Talbman; D J Smith
Journal:  Infect Immun       Date:  1974-06       Impact factor: 3.441

10.  An immunological relationship between the group. A streptococcus and mammalian muscle.

Authors:  J B Zabriskie; E H Freimer
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

View more
  49 in total

Review 1.  Passive immunity against human pathogens using bovine antibodies.

Authors:  C Weiner; Q Pan; M Hurtig; T Borén; E Bostwick; L Hammarström
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

2.  Streptococcus sobrinus antigens that react to salivary antibodies induced by tonsillar application of formalin-killed S. sobrinus in rabbits.

Authors:  T Fukuizumi; H Inoue; T Tsujisawa; C Uchiyama
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Restriction fragment length polymorphisms and sequence variation within the spaP gene of Streptococcus mutans serotype c isolates.

Authors:  L J Brady; P J Crowley; J K Ma; C Kelly; S F Lee; T Lehner; A S Bleiweis
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

Review 4.  Recent advances in the development of a Streptococcus mutans vaccine.

Authors:  J P Klein; M Scholler
Journal:  Eur J Epidemiol       Date:  1988-12       Impact factor: 8.082

5.  Further characterization of immunomodulation by a monoclonal antibody against Streptococcus mutans antigen P1.

Authors:  Nikki R Rhodin; Marloes L J A Van Tilburg; Monika W Oli; William P McArthur; L Jeannine Brady
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

6.  Binding of Streptococcus mutans antigens to heart and kidney basement membranes.

Authors:  M W Stinson; P K Barua; E J Bergey; R J Nisengard; M E Neiders; B Albini
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

7.  Differentiation of salivary agglutinin-mediated adherence and aggregation of mutans streptococci by use of monoclonal antibodies against the major surface adhesin P1.

Authors:  L J Brady; D A Piacentini; P J Crowley; P C Oyston; A S Bleiweis
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

8.  Local passive immunization by monoclonal antibodies against streptococcal antigen I/II in the prevention of dental caries.

Authors:  T Lehner; J Caldwell; R Smith
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

9.  Identification of monoclonal antibody-binding domains within antigen P1 of Streptococcus mutans and cross-reactivity with related surface antigens of oral streptococci.

Authors:  L J Brady; D A Piacentini; P J Crowley; A S Bleiweis
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

10.  Binding of Streptococcus mutans SR protein to human monocytes: production of tumor necrosis factor, interleukin 1, and interleukin 6.

Authors:  M Soell; F Holveck; M Schöller; R D Wachsmann; J P Klein
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.